A Phase I Study of Sirolimus in Combination With Oral Cyclophosphamide and Oral Topotecan in Children and Young Adults With Relapsed and Refractory Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Sirolimus (Primary) ; Cyclophosphamide; Topotecan
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 20 Jun 2017 Status changed from active, no longer recruiting to completed.
- 14 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.